Literature DB >> 32445231

Eat All Through Radiation Therapy (EAT-RT): Structured therapy model to facilitate continued oral intake through head and neck radiotherapy-User acceptance and content validation.

Katherine A Hutcheson1,2, Andrea Gomes3, Veronica Rodriguez4, Denise Barringer1, Maisha Khan4, Rosemary Martino4,5,6,7.   

Abstract

BACKGROUND: To develop and examine user acceptance and content validity of a structured program to facilitate safe but challenging oral intake during radiotherapy (RT) delivered by a speech language pathologist (SLP)-the Eat-All Through Radiation Therapy (EAT-RT) program.
METHODS: EAT-RT was developed through expert consensus of SLPs at the Princess Margaret Cancer Centre (Canada) and M D Anderson Cancer Center using a conceptual framework of a diet hierarchy and a mealtime routine. EAT-RT was refined by practicing SLPs, and then disseminated for a 4-week clinical pilot at seven sites who were subsequently invited to participate in an online survey.
RESULTS: Twelve SLPs from six sites piloted EAT-RT therapy with a median of eight patients (IQR: 2-15) before and/or during RT. All SLPs reported EAT-RT added value to their practice, harmonized well with exercises, and its content was helpful; 11 (92%) reported EAT-RT facilitated patient understanding and indicated the desire to continue using EAT-RT.
CONCLUSION: The EAT-RT program was accepted by North American SLPs. The findings support the content and value of EAT-RT to facilitate oral intake in patients with head and neck cancer throughout RT.
© 2020 Wiley Periodicals, Inc.

Entities:  

Keywords:  dysphagia; head and neck cancer; radiation; supportive care; swallowing therapy

Mesh:

Year:  2020        PMID: 32445231     DOI: 10.1002/hed.26250

Source DB:  PubMed          Journal:  Head Neck        ISSN: 1043-3074            Impact factor:   3.147


  2 in total

1.  The PRO-ACTIVE trial protocol: a randomized study comparing the effectiveness of PROphylACTic swallow InterVEntion for patients receiving radiotherapy for head and neck cancer.

Authors:  R Martino; M I Fitch; C D Fuller; A Hope; G Krisciunas; S E Langmore; C Lazarus; C L Macdonald; T McCulloch; G Mills; D A Palma; K Pytynia; J Ringash; K Sultanem; J Theurer; K E Thorpe; K Hutcheson
Journal:  BMC Cancer       Date:  2021-10-13       Impact factor: 4.430

2.  Exploring patient experiences with a telehealth approach for the PRO-ACTIVE trial intervention in head and neck cancer patients.

Authors:  M M Khan; B Manduchi; V Rodriguez; M I Fitch; C E A Barbon; H McMillan; K A Hutcheson; R Martino
Journal:  BMC Health Serv Res       Date:  2022-09-30       Impact factor: 2.908

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.